UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000036934 |
|---|---|
| Receipt number | R000042093 |
| Scientific Title | Analysis of skin molecules in healthy females. |
| Date of disclosure of the study information | 2019/06/03 |
| Last modified on | 2019/12/04 14:44:51 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Analysis of skin molecules in healthy females.
Acronym
Analysis of skin molecules in healthy females.
Scientific Title
Analysis of skin molecules in healthy females.
Scientific Title:Acronym
Analysis of skin molecules in healthy females.
Region
| Japan |
Condition
Condition
Healthy adults
Classification by specialty
| Not applicable | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Evaluation of skin molecules in healthy females.
Basic objectives2
Others
Basic objectives -Others
Evaluation of skin molecules in healthy females.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The relationship between skin and skin surface molecules in healthy females.
Key secondary outcomes
Comparison of molecules between epidermis, hair follicles, sweat glands, and sebaceous glands.
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 59 | years-old | >= |
Gender
Female
Key inclusion criteria
Healthy female
Key exclusion criteria
(1) Subjects who have the skin diseases, such as atopic dermatitis, acne vulgaris, and psoriasis vulgaris.
(2) Subjects who use the antibiotics within 2 weeks before participation in this study.
(3) Subjects who use the prescription drugs having any effects to this study.
(4) Subjects who use the prescription topical agents on the head.
(5)-Subjects who are deemed inappropriate to participate in this study by the principle investigator.
Target sample size
10
Research contact person
Name of lead principal investigator
| 1st name | Takayoshi |
| Middle name | |
| Last name | Inoue |
Organization
Kao Corporation
Division name
Biological Science Research
Zip code
321-3497
Address
2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan
TEL
+81-285-68-7888
inoue.takayoshi@kao.com
Public contact
Name of contact person
| 1st name | Tetsuya |
| Middle name | |
| Last name | Kuwano |
Organization
Kao Corporation
Division name
Biological Science Research
Zip code
321-3497
Address
2606, Akabane, Ichikai-machi, Haga-gun, Tochigi, 321-3497, Japan
TEL
+81-285-68-7888
Homepage URL
kuwano.tetsuya@kao.com
Sponsor or person
Institute
Kao Corporation
Institute
Department
Personal name
Funding Source
Organization
Kao Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
BizCom Japan, Inc.
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Human Research Ethics Committee, Kao Corporation
Address
2-1-3, Bunka, Sumida-ku, Tokyo 131-8501, JAPAN
Tel
+81-3-5630-9220
uesaka.toshio@kao.co.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 06 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2019 | Year | 05 | Month | 20 | Day |
Date of IRB
| 2019 | Year | 05 | Month | 20 | Day |
Anticipated trial start date
| 2019 | Year | 06 | Month | 03 | Day |
Last follow-up date
| 2019 | Year | 12 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Evaluation of skin molecules in healthy females.
Management information
Registered date
| 2019 | Year | 06 | Month | 03 | Day |
Last modified on
| 2019 | Year | 12 | Month | 04 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042093
